Delivery Order SPE2DB22D9225-SPE2DB24FR8EE
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for the supply of a pharmaceutical product, JAKAFI 10 MG TABLET 60S, with a potential value of $11,840.66 and a completion date of January 19, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription and over-the-counter drug supplies to the federal government,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical item JAKAFI 5 MG TABLET 60S. The $106,198.92 order is part of a larger indefinite delivery contract between DMS Pharmaceutical Group and DLA to supply a variety of pharmaceutical and medical products in support of military treatment facilities worldwide. This delivery order has a completion date of July 12, 2022. DMS...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for the supply of a pharmaceutical product, JAKAFI 15 MG TABLET 60S, with a potential value of $11,773.87 and a completion date of January 9, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription and over-the-counter drug supplies to the federal...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of JAKAFI 10 MG TABLET 60S, a prescription drug product, with a total potential value of $23,719.30. The contract is a firm fixed-price, delivery order type and does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract with the DLA, valued up...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $35,521.98 contract is for the delivery of JAKAFI 10 MG TABLET 60S, a prescription pharmaceutical product, with a completion date of January 5, 2024. DMS Pharmaceutical Group has held numerous prior contracts and delivery orders with DLA Troop Support Medical to provide a wide range of pharmaceutical and medical...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $47,399.24 contract provides for the delivery of the drug JAKAFI 5 MG TABLET 60S to support military treatment facilities. DMS Pharmaceutical Group holds multiple contracts and indefinite delivery vehicles with DLA Troop Support Medical to supply a wide range of pharmaceutical and medical products. This specific order...
- This is a $24,179.58 firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA) to provide JAKAFI 20 MG TABLET 60S. The delivery order has an ultimate completion date of June 26, 2025. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler that specializes in supplying a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The $100,730.80 contract is for the supply of pharmaceutical items such as the drug JAKAFI. DMS Pharmaceutical Group holds various federal contracts and indefinite delivery vehicles (IDVs) to provide pharmaceuticals and medical supplies to support military treatment facilities worldwide. This particular delivery order is...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract has a potential value of $11,840.66 and a completion date of January 23, 2024. It is for the delivery of the pharmaceutical product JAKAFI 10 MG TABLET 60S. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription and over-the-counter drug supplies to the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $12,146.79 contract is for the delivery of JAKAFI 5 MG TABLET 60S, a specialized prescription medication, with a completion date of February 6, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue firm...
- SPE2DB22D9225Indefinite Delivery Contract
- SPE2DB22D9225-SPE2DB24FR8EEDelivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The $32,842.02 contract is to deliver JAKAFI 5 MG TABLET 60S to support the operations of DLA Troop Support Medical facilities. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that provides brand and generic prescription drugs and over-the-counter medical supplies to the federal government, primarily the Department of Defense. This delivery order is part of a larger indefinite delivery contract with DLA Troop Support Medical to provide a variety of pharmaceutical items and medical supplies, with a potential value up to $5 million through December 2025. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.8k | 12/28/23 |